1、 MARTIN V,LEE L A,ASKANASE A D,et al.Long-term followup of children with neonatal lupus and their unaffected siblings[J].Arthritis Rheum,2002,46(9):2377-2383. MARTIN V,LEE L A,ASKANASE A D,et al.Long-term followup of children with neonatal lupus and their unaffected siblings[J].Arthritis Rheum,2002,46(9):2377-2383.
2、 RIVERA T L,IZMIRLY P M,BIRNBAUM B K,et al.Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus[J].Ann Rheum Dis,2009,68(6):828-835. RIVERA T L,IZMIRLY P M,BIRNBAUM B K,et al.Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus[J].Ann Rheum Dis,2009,68(6):828-835.
3、 MOAK J P,BARRON K S,HOUGEN T J,et al.Congenital heart block: development of late-onset cardiomyopathy,a previously underappreciated sequela[J].J Am Coll Cardiol,2001,37(1):238-242. MOAK J P,BARRON K S,HOUGEN T J,et al.Congenital heart block: development of late-onset cardiomyopathy,a previously underappreciated sequela[J].J Am Coll Cardiol,2001,37(1):238-242.
4、 IZMIRLY P M,SAXENA A,SAHL S K,et al.Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system[J].Ann Rheum Dis,2016,75(6):1161-1165. IZMIRLY P M,SAXENA A,SAHL S K,et al.Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system[J].Ann Rheum Dis,2016,75(6):1161-1165.
5、 BUYON J P,CLANCY R M.From antibody insult to fibrosis in neonatal lupus - the heart of the matter[J].Arthritis Res Ther,2003,5(6):266-270. BUYON J P,CLANCY R M.From antibody insult to fibrosis in neonatal lupus - the heart of the matter[J].Arthritis Res Ther,2003,5(6):266-270.
6、 MIYAGAWA S.Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical,serological and immunogenetic features of Japanese versus Caucasian patients[J].J Dermatol,2005,32(7):514-522. MIYAGAWA S.Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical,serological and immunogenetic features of Japanese versus Caucasian patients[J].J Dermatol,2005,32(7):514-522.
7、 BOH E E.Neonatal lupus erythematosus[J].Clin Dermatol,2004,22(2):125-128. BOH E E.Neonatal lupus erythematosus[J].Clin Dermatol,2004,22(2):125-128.
8、 AMBROSI A,SONESSON S-E,WAHREN-HERLENIUS M.Molecular mechanisms of congenital heart block[J].Exp Cell Res,2014,325(1):2-9. AMBROSI A,SONESSON S-E,WAHREN-HERLENIUS M.Molecular mechanisms of congenital heart block[J].Exp Cell Res,2014,325(1):2-9.
9、 CAPONE C,BUYON J P,FRIEDMAN D M,et al.Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population[J].Cardiol Rev,2012,20(2):72-76. CAPONE C,BUYON J P,FRIEDMAN D M,et al.Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population[J].Cardiol Rev,2012,20(2):72-76.
10、 LI Y-Q,WANG Q,LUO Y,et al.Neonatal lupus erythematosus: a review of 123 cases in China[J].Int J Rheum Dis,2015,18(7):761-767. LI Y-Q,WANG Q,LUO Y,et al.Neonatal lupus erythematosus: a review of 123 cases in China[J].Int J Rheum Dis,2015,18(7):761-767.
11、 BUYON J P,CLANCY R M,FRIEDMAN D M.Cardiac manifestations of neonatal lupus erythematosus: guidelines to management,integrating clues from the bench and bedside[J].Nat Clin Pract Rheumatol,2009,5(3):139-148. BUYON J P,CLANCY R M,FRIEDMAN D M.Cardiac manifestations of neonatal lupus erythematosus: guidelines to management,integrating clues from the bench and bedside[J].Nat Clin Pract Rheumatol,2009,5(3):139-148.
12、 LIAO H,TANG C,QIAO L,et al.Prenatal management strategy for immune-associated congenital heart block in fetuses[J].Front Cardiovasc Med,2021(8):644122. LIAO H,TANG C,QIAO L,et al.Prenatal management strategy for immune-associated congenital heart block in fetuses[J].Front Cardiovasc Med,2021(8):644122.
13、 ACHERMAN R J,FRIEDMAN D M,BUYON J P,et al.Doppler fetal mechanical PR interval prolongation with positive maternal anti-RNP but negative SSA/Ro and SSB/La auto-antibodies[J].Prenat Diagn,2010,30(8):797-799. ACHERMAN R J,FRIEDMAN D M,BUYON J P,et al.Doppler fetal mechanical PR interval prolongation with positive maternal anti-RNP but negative SSA/Ro and SSB/La auto-antibodies[J].Prenat Diagn,2010,30(8):797-799.
14、 LEE L A,SOKOL R J,BUYON J P.Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry[J].Pediatrics,2002,109(1):E11. LEE L A,SOKOL R J,BUYON J P.Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry[J].Pediatrics,2002,109(1):E11.
15、 BRITO-ZERóN P,IZMIRLY P M,RAMOS-CASALS M,et al.The clinical spectrum of autoimmune congenital heart block[J].Nat Rev Rheumatol,2015,11(5):301-312. BRITO-ZERóN P,IZMIRLY P M,RAMOS-CASALS M,et al.The clinical spectrum of autoimmune congenital heart block[J].Nat Rev Rheumatol,2015,11(5):301-312.
16、 JAEGGI E T,HAMILTON R M,SILVERMAN E D,et al.Outcome of children with fetal,neonatal or childhood diagnosis of isolated congenital atrioventricular block[J].J Am Coll Cardiol,2002,39(1):130-137. JAEGGI E T,HAMILTON R M,SILVERMAN E D,et al.Outcome of children with fetal,neonatal or childhood diagnosis of isolated congenital atrioventricular block[J].J Am Coll Cardiol,2002,39(1):130-137.
17、 IZMIRLY P M,SAXENA A,KIM M Y,et al.Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus[J].Circulation,2011,124(18):1927-1935. IZMIRLY P M,SAXENA A,KIM M Y,et al.Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus[J].Circulation,2011,124(18):1927-1935.
18、 BUYON J P,CLANCY R M.Neonatal lupus syndromes[J].Curr Opin Rheumatol,2003,15(5):535-541. BUYON J P,CLANCY R M.Neonatal lupus syndromes[J].Curr Opin Rheumatol,2003,15(5):535-541.
